
Onglets principaux
Exporter 15 resultats:
Filtres: Auteur is Stéphanie Depickère
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients,
, Vaccine, Jan-01-2025, Volume 44, (2025)
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.,
, Vaccine, 2025 Jan 12, Volume 44, (2025)
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers,
, March 2025, Volume eBiomedicine, Issue Volume 113, (2025)
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers,
, eBioMedicine, Jan-03-2025, Volume 113, (2025)
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients,
, Kidney International Reports, Jan-03-2024, Volume 9, Issue 3, Number 648, (2024)
Monitoring of the immune response to SARS-CoV-2 in vulnerable populations: the COVICO study (2023-2026),
, Scientific Seminar ‘Diagnosis and surveillance of infectious diseases’ 2024, Issue Sciensano, (2024)
Non-invasive infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023.,
, Euro Surveill, 2024 Nov, Volume 29, Issue 45, (2024)
Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023,
, Euro Surveill, Volume 29, Issue 45, (2024)
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.,
, J Heart Lung Transplant, 2024 Aug 10, (2024)
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.,
, J Heart Lung Transplant, 2024 Aug 10, (2024)
Belgian SARS-CoV-2 Vaccination studies (BelCoVac) report,
, 10/2023, Brussel, Belgium, p.28, (2023)
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.,
, Am J Transplant, 2023 May, Volume 23, Issue 5, (2023)
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.,
, Vaccine, 2023 Apr 24, Volume 41, Issue 17, (2023)
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial,
, PLOS Global Public Health, Dec-20-2022, Volume 2, Issue 12, (2022)